U.S., Aug. 28 -- An application to own the trademark for 'HIDAR' has been filed on Apr. 16, 2025.
Owner(s):
Myris Therapeutics Inc.; 307 23rd St Ext, Suite 150, PENNSYLVANIA
Goods and/or Services:
For: Pharmaceutical preparations for oncology
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-08-26&serialNumber=99139819
Disclaimer: Curated by HT Syndication....